Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48

被引:0
|
作者
Tianzhuo Zhang
Qin Fang
Ping Liu
Ping Wang
Cheng Feng
Jishi Wang
机构
[1] Guizhou Medical University,Department of Clinical Medical School
[2] Affiliated Hospital of Guizhou Medical University,Department of Hematology
[3] Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre,Department of Pharmacy
[4] Affiliated Hospital of Guizhou Medical University,undefined
关键词
Acute myeloid leukemia; Heme oxygenase 1; Natural killer cells; CD48; Sirt1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Natural killer cells expanded under good manufacturing practice conditions exert lytic activity against acute myeloid leukemia blasts
    Mascolo, M. G.
    Torelli, G. F.
    Ricciardi, M. R.
    De Propris, M. S.
    Milano, F.
    Lucarelli, B.
    Valle, V.
    Lannella, E.
    Arleo, E.
    Iori, A. P.
    Tafuri, A.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 95 - 96
  • [32] Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice
    Siegler, U
    Kalberer, CP
    Nowbakht, P
    Sendelov, S
    Meyer-Monard, S
    Wodnar-Filipowicz, A
    LEUKEMIA, 2005, 19 (12) : 2215 - 2222
  • [33] Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation
    Tao, Yan-Fang
    Li, Zhi-Heng
    Du, Wei-wei
    Xu, Li-xiao
    Ren, Jun-Li
    Li, Xiao-Lu
    Fang, Fang
    Xie, Yi
    Wu, Yi
    Feng, Xing
    Wang, Jian
    He, Wei-Qi
    Hu, Shao-Yan
    Lu, Jun
    Pan, Jian
    ONCOLOGY REPORTS, 2017, 37 (03) : 1419 - 1429
  • [34] The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
    Sadeghi, Mohammad
    Moslehi, Asma
    Kheiry, Hadiseh
    Kiani, Fariba Karoon
    Zarei, Asieh
    Khodakarami, Atefeh
    Karpisheh, Vahid
    Masjedi, Ali
    Rahnama, Badrossadat
    Hojjat-Farsangi, Mohammad
    Raeisi, Mortaza
    Yousefi, Mehdi
    Akbari, Ali Akbar Movasaghpour
    Jadidi-Niaragh, Farhad
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [35] Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
    Wiernik, Andres
    Foley, Bree
    Zhang, Bin
    Verneris, Michael R.
    Warlick, Erica
    Gleason, Michelle K.
    Ross, Julie A.
    Luo, Xianghua
    Weisdorf, Daniel J.
    Walcheck, Bruce
    Vallera, Daniel A.
    Miller, Jeffrey S.
    CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3844 - 3855
  • [36] Ex Vivo Expansion of Cord Blood Natural Killer Cells Overcomes Impaired Immune Synapse Formation and Effector Function in Acute Myeloid Leukemia
    Xing, Dongxia
    Ramsay, Alan G.
    Gribben, John G.
    Decker, William K.
    Burt, Jared K.
    Li, Sufang
    Simon, Simon N.
    Yang, Hong
    Cooper, Laurence
    McMannis, John D.
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Zweidler-McKay, Patrick
    Bollard, Catherine M.
    BLOOD, 2008, 112 (11) : 999 - 999
  • [37] CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
    Baatz, F.
    Herbst, J.
    Schambach, A.
    Hust, M.
    Maetzig, T.
    Meyer, J.
    Sauer, M. G.
    KLINISCHE PADIATRIE, 2022, 234 (03): : 175 - 176
  • [38] Comparison of CD28-and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia
    Gierschek, F.
    Albinger, N.
    Wendel, P.
    Born, A.
    Bhayadia, R.
    Klusmann, J. H.
    Ullrich, E.
    KLINISCHE PADIATRIE, 2023, 235 (03): : 195 - 195
  • [39] A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia
    Fehniger, Todd A.
    Miller, Jeffrey S.
    Stuart, Robert K.
    Cooley, Sarah
    Salhotra, Amandeep
    Curtsinger, Julie
    Westervelt, Peter
    DiPersio, John F.
    Hillman, Timothy M.
    Silver, Nova
    Szarek, Michael
    Gorelik, Leonid
    Lowdell, Mark W.
    Rowinsky, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1581 - 1589
  • [40] The Contribution of Signaling Endodomains to CD33-Mediated Killing of Acute Myeloid Leukemia by Natural Killer Cells Transiently Modified with Chimeric Antigen Receptor
    Friesen, Jeffrey
    Senyukov, Vladimir
    Denman, Cecele J.
    Somanchi, Srinivas S.
    Olivares, Simon
    Cooper, Laurence J. N.
    Lee, Dean A.
    BLOOD, 2009, 114 (22) : 971 - 971